Biotech Mesoblast to be hit with class action over COVID-19 treatment disclosures
Class Actions 2021-04-22 9:25 pm By Cindy Cameronne | Sydney

Save(0) Please login to bookmark Username or Email Address Password Remember Me Australian regenerative medicine company Mesoblast faces a shareholder class action over disclosures related […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.